Related Experiment Video

Updated: May 13, 2026

Induction and Analysis of Epithelial to Mesenchymal Transition
10:37

Induction and Analysis of Epithelial to Mesenchymal Transition

Published on: August 27, 2013

MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells

P Ceppi1, M E Peter1

  • 1Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Oncogene
|March 5, 2013
PubMed

Insights

This review explores how microRNAs (small noncoding RNA molecules) regulate cancer plasticity, linking key concepts like epithelial-to-mesenchymal transition and cancer stem cells. Understanding this connection offers new strategies for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Basic research has advanced molecular oncology, improving understanding of tumor nature and progression.
  • Key concepts include epithelial-to-mesenchymal transition and cancer stem cell hypothesis.
  • Cancer plasticity is a critical area of research.

Purpose of the Study:

  • To review the regulatory role of microRNAs in cancer plasticity.
  • To discuss the link between microRNAs, epithelial-to-mesenchymal transition, and cancer stem cells.
  • To explore implications for cancer treatment strategies.

Main Methods:

  • Literature review of current research on microRNAs and cancer.
  • Analysis of studies on epithelial-to-mesenchymal transition and cancer stem cells.
  • Synthesis of evidence connecting these molecular mechanisms.

Main Results:

  • MicroRNAs are identified as key regulators of cancer plasticity.
  • Evidence supports a functional association between microRNAs, EMT, and CSCs.
  • These molecular interactions are crucial for tumor progression.

Conclusions:

  • MicroRNAs play a fundamental role in connecting major cancer models.
  • Targeting microRNA pathways presents potential therapeutic strategies.
  • Further research into microRNA-mediated cancer plasticity is warranted for effective cancer control.

More Related Videos

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...